Drug Search Results
More Filters [+]

EPI-111

Alternative Names: EPI-111, EPI111
Latest Update: 2023-03-28
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Gene Therapy,PRPF31

Novel Mechanism: Yes

Modality: Gene Therapy

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Epic Bio
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for EPI-111

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 0: Retinitis Pigmentosa

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title